Tyrosine.

After tyrosine is converted to L-DOPA, the enzyme that decarboxylates it into dopamine depends on the active form of vitamin B6 as its cofactor. Tyrosine supplies the building block and B6 keeps the enzyme that acts on it running.

Tyrosine hydroxylase, which takes the first and slowest step of turning tyrosine into dopamine's precursor, holds iron at its active site and cannot run without it. Iron therefore paces the step where tyrosine enters catecholamine production.

The enzyme that converts dopamine into norepinephrine uses vitamin C as the electron donor it needs on each cycle. Because that dopamine traces back to tyrosine, vitamin C supports the following step in the same chain.

Thyroid hormone is assembled by attaching iodine onto tyrosine, so the two are the raw materials the body builds it from. Tyrosine contributes the amino acid backbone and iodine is the element added onto it.

Dopamine beta-hydroxylase, which converts dopamine to noradrenaline, is a copper enzyme, and tyrosinase in pigment formation is another. Copper status gates those steps downstream of tyrosine.

Phenylalanine hydroxylase converts phenylalanine into tyrosine directly. It sits one step upstream of the entire catecholamine route.

The L-form is hydroxylated to tyrosine, feeding the catecholamine route from one step back. The pair supplies the pathway at two consecutive points.

Thyroid hormone is built from iodinated tyrosine residues and activated by selenium-dependent deiodinases. Tyrosine and iodine give the structure, selenium runs the conversion.

S-adenosyl methionine donates the methyl group turning noradrenaline into adrenaline and is used again when catecholamines are inactivated. Methyl availability shapes the fate of tyrosine-derived transmitters.

Betaine remethylates homocysteine to methionine and so replenishes the S-adenosyl methionine spent on catecholamine methylation. It keeps that methyl pool stocked.

Tetrahydrobiopterin, the cofactor for tyrosine hydroxylase, is salvaged by dihydrofolate reductase, and folate also refills the downstream methyl pool. Both points sit on the catecholamine route.

Tyrosine and tryptophan compete for the same carrier into the brain and later for aromatic amino acid decarboxylase. Loading one lowers central delivery of the other.

5-HTP and tyrosine-derived L-dopa are both substrates for aromatic amino acid decarboxylase and its B6 cofactor. Heavy use of one draws on the same enzyme the other needs.

Branched-chain amino acids compete with tyrosine for the large neutral amino acid carrier at the brain barrier. A large leucine dose reduces tyrosine entry.

Valine uses the same large neutral amino acid carrier tyrosine needs. High doses taken together compete for that transport.

Mucuna supplies L-dopa, the product of the tyrosine hydroxylase step. It joins the catecholamine route past the usual limiting point.

Tyrosine feeds catecholamine synthesis while theanine lowers arousal and raises alpha activity. The pairing targets focus without an edgy feel.

Caffeine raises catecholamine signalling and turnover while tyrosine supplies what those transmitters are made from. Substrate plus stimulus is long-standing formulation practice.

Zinc takes part in thyroid hormone metabolism and in the receptor that reads it, downstream of the iodinated tyrosine backbone. It sits on the axis tyrosine and iodine feed.

Catechol O-methyltransferase, the enzyme that methylates dopamine and noradrenaline once they have been formed from tyrosine, is magnesium dependent. Magnesium status therefore sits on the clearance side of the same pathway tyrosine feeds. This is a cofactor relationship read from enzymology, not a measured combination effect.

Tyrosine hydroxylase needs tetrahydrobiopterin, and the pterin is regenerated by dihydropteridine reductase using NADH. Niacin is the dietary precursor of the NAD pool that supplies that reducing equivalent. Without pterin recycling the first and rate-limiting step of catecholamine synthesis stalls regardless of how much tyrosine is present.

Conversion of noradrenaline to adrenaline uses S-adenosylmethionine as the methyl donor, and SAM regeneration runs through the B12 dependent methionine synthase step. B12 status is therefore upstream of the last methylation in the tyrosine branch. The link is biochemical rather than a tested pairing.

Aromatic L-amino acid decarboxylase converts L-DOPA to dopamine using pyridoxal 5-phosphate as its cofactor. P5P is the already-phosphorylated form of that cofactor, so it enters the pool without the hepatic conversion step. The relationship is settled enzymology.

Tyrosine crosses the blood brain barrier on the LAT1 large neutral amino acid carrier, which methionine also uses. A large simultaneous load of one reduces carrier availability for the other. Spacing the two apart is the usual formulation answer, and the competition is transport level, not an effect on synthesis.

Where tyrosinase acts on tyrosine, the presence of cysteine diverts the intermediate toward sulfur-containing pigment rather than the eumelanin route. Dietary cystine plus tyrosine shifted pigment composition in Pacific oysters, which is an animal model of pigment chemistry rather than a human result. The chemistry of the branch point is well described.

Catechins including EGCG are substrates and competitive inhibitors of catechol O-methyltransferase, the enzyme that clears catecholamines made from tyrosine. Slower methylation shifts the balance between formation and clearance. This is enzyme kinetics observed in laboratory systems, not a measured outcome from taking the two together.

Quercetin carries a catechol-type B ring and is handled by catechol O-methyltransferase, so it competes for the same methylation capacity that clears dopamine and noradrenaline. The interaction is well characterised in vitro. What it does to catecholamine tone in a person taking both has not been measured here.

Rhodiola constituents are described as acting on monoamine turnover, the same pool tyrosine supplies precursor to. Formulators combine the two in demand-and-clearance stacks for that reason. No combination trial grounds the pairing, so read it as mechanistic rather than clinical.

Alpha-GPC feeds choline for acetylcholine synthesis while tyrosine feeds the catecholamine branch. The two supply different transmitter pools rather than competing for one, which is why they appear together in precursor blends. Each precursor relationship is established on its own; the combination itself is untested here.

Ashwagandha is used for its effect on the stress axis, while tyrosine supplies substrate that catecholamine synthesis draws down under demand. Products pair a substrate with an axis modulator on that logic. The rationale is mechanistic and the pairing has not been measured directly.